ArticleBlood2020
Predicting success of desensitization after pegaspargase allergy.
Article in Blood, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study.British journal of haematology · 2025Observational
- NPM1 Measurable Residual Disease: A Narrative Review.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025Review
- Desensitization to calaspargase pegol appears to be less successful than pegaspargase.Blood advances · 2025Article
- A 12-Step Desensitization Protocol for Calaspargase Pegol-mknl.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025Article
- Follow our path with asparaginase activity: one technique, but different uses in clinical practice.Experimental hematology & oncology · 2022Article
- The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience.The journal of allergy and clinical immunology. In practice · 2022Article
- Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.Frontiers in pediatrics · 2022Review
- An injectable excipient prevents anti-polyethylene glycol antibody-mediated hypersensitivity.Allergy · 2021Article
- Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.The journal of allergy and clinical immunology. In practice · 2021Review
- Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2021Article
- Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion.ESMO open · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.